Literature DB >> 27527610

L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Ana Beatriz Santoro1,2, Claudio José Struchiner3, Guilherme Suarez-Kurtz4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27527610      PMCID： PMC5061780          DOI： 10.1111/bcp.13064

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Authors:  Ana Beatriz Santoro; Claudio José Struchiner; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2016-08-16       Impact factor: 4.335

2.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

3.  A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients.

Authors:  S Chen; I Laverdiere; A Tourancheau; D Jonker; F Couture; E Cecchin; L Villeneuve; M Harvey; M H Court; F Innocenti; G Toffoli; E Lévesque; C Guillemette
Journal:  Pharmacogenomics J       Date:  2015-03-17       Impact factor: 3.550

4.  Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer.

Authors:  Ana B Santoro; Daniela D Vargens; Mateus de Camargo Barros Filho; Daniel A Bulzico; Luiz Paulo Kowalski; Ricardo M R Meirelles; Daniela P Paula; Ronaldo R S Neves; Cencita N Pessoa; Claudio J Struchine; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

5.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
  5 in total
  1 in total

1.  L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Authors:  Ana Beatriz Santoro; Claudio José Struchiner; Guilherme Suarez-Kurtz
Journal:  Br J Clin Pharmacol       Date:  2016-08-16       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.